Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study.
Zhiyuan FanYu QinJing ZhouRu ChenJianhua GuMinjuan LiJiachen ZhouXinqing LiDongmei LinJinwu WangDajun DengWen-Qiang WeiPublished in: Cancer medicine (2022)
P16 methylation as a cytologic marker was associated with the ESCC development and has the potential for application in minimally invasive ESCC screening.